Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
222.80    0.20 (0.09%)
Bid:
222.60
Ask:
223.00
Spread: 0.40 (0.18%)
Market Cap: £2.28b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Conditional Redemption of Senior Notes

20 May 2024 08:15

RNS Number : 0664P
Helios Towers PLC
20 May 2024
Β 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) 596/2014

NOT FOR DISTRIBUTION IN OR INTO ANY JURISDICTION OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION IN WHICH SUCH DISTRIBUTION IS UNLAWFUL

Β 

HELIOS TOWERS ANNOUNCES CONDITIONAL NOTICE OF REDEMPTION FOR ALL OF ITS OUTSTANDING 7.000% SENIOR NOTES DUE 2025

May 20, 2024 - HTA Group, Ltd (the "Issuer"), an indirect wholly owned subsidiary of Helios Towers plc (the "Company"), announces it has issued a conditional notice of redemption for all of its outstanding 7.000% Senior Notes due 2025 (the "Notes"). As set forth in the conditional notice of redemption issued today in respect of the Notes, the redemption date is June 18, 2024 (the "Redemption Date") unless the Redemption Date is delayed or revoked by the Issuer, and the redemption price for the Notes is 100.000% of the principal amount thereof, plus the amount of accrued and unpaid interest to, but excluding, the Redemption Date.

On the date hereof, the Issuer also announced (i) its offer to purchase for cash any and all of the Notes (the "Tender Offer") and (ii) an offering of new U.S. dollar-denominated senior notes subject to market conditions (the "New Notes Offering"). Any notes issued pursuant to the New Notes Offering and the guarantees in respect thereof have not been and will not be registered under the United States Securities Act of 1933. Neither the Tender Offer nor this announcement is an offer to sell or a solicitation of an offer to buy any notes issued pursuant to the New Notes Offering. No action has been or will be taken in any jurisdiction in relation to any notes issued pursuant to the New Notes Offering to permit a public offering of securities. This notice does not constitute an offer to sell, or a solicitation of an offer to buy, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation or sale would be unlawful.

The redemption is subject to and conditioned upon the successful completion (in the sole determination of the Issuer) of the New Notes Offering.

Forward-Looking Information

Certain statements included herein may constitute forward-looking statements within the meaning of the securities laws of certain jurisdictions. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as "believes", "expects", "may", "are expected to", "intends", "will", "will continue", "should", "would be", "seeks", "anticipates" or similar expressions or the negative thereof or other variations thereof or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Issuer concerning, among other things, the results in relation to operations, financial condition, liquidity, prospects, growth and strategies of the Issuer and the industry in which it operates. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

These forward-looking statements speak only as of the date of this announcement. The Issuer does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCQBLBLZELXBBE
Date   Source Headline
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding
7th Jun 20229:57 amRNSOmantel Tower Acquisition Update
5th May 202210:30 amRNSCapital Markets Day 2022
5th May 20227:00 amRNSQ1 2022 Results
29th Apr 202212:29 pmRNSDirector/PDMR Shareholding
28th Apr 20222:58 pmRNS2022 Annual General Meeting Results
20th Apr 202212:37 pmRNSNotice of Q1 2022 Results Date and CMD
28th Mar 20222:04 pmRNS2021 Annual Report & Accounts & 2022 Notice of AGM
25th Mar 20227:00 amRNSClosing of tower acquisition in Malawi
24th Mar 20229:11 amRNSDirector Declaration
21st Mar 20225:08 pmRNS2021 Annual Report and Accounts
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSFinal Results
10th Mar 20227:00 amRNSBoard Update - Director Changes
25th Feb 20227:00 amRNSAirtel Africa Tower Portfolio Transactions Update
11th Feb 20227:00 amRNSOmantel tower acquisition long-stop date extension
2nd Feb 20229:00 amRNSNotice of FY2021 Results Date & Conference Call
14th Dec 20212:12 pmRNSHolding(s) in Company
1st Dec 20215:12 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSCarbon Reduction Roadmap
3rd Nov 20217:00 amRNSClosing of tower acquisition in Madagascar
28th Oct 20217:00 amRNSQ3 2021 Results
22nd Oct 20218:25 amRNSDirector Declaration
11th Oct 20217:00 amRNSNotice of Q3 2021 Results Date & Conference Call
27th Sep 20213:33 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSUnaudited results for the 6 months ended 30 Jun 21
18th Aug 20215:00 pmRNSHelios Towers Announces CEO Transition
4th Aug 20217:00 amRNSNotice of H1 2021 Results Date & Conference Call
2nd Jul 20219:48 amRNSHolding(s) in Company
2nd Jul 20219:47 amRNSDirector/PDMR Shareholding
30th Jun 20216:11 pmRNSHolding(s) in Company
30th Jun 202111:12 amRNSTotal Voting Rights
18th Jun 20219:25 amRNSTotal Voting Rights
17th Jun 202112:46 pmRNSDirector/PDMR Shareholding
16th Jun 20217:00 amRNSResults of Placing
15th Jun 20215:06 pmRNSRetail Offer via Primary Bid
15th Jun 20214:57 pmRNSLaunch of placing & convertible bond tap issuance
4th Jun 202112:46 pmRNSResult of General Meeting
3rd Jun 20215:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.